“We continue to make rapid progress reimagining drug design from first principles with AI to radically cut the time & cost to find new medicines”
Hassabis lands $5B for Isomorphic Labs and AI drug design
Alphabet's drug design shop just raised $5B in a Series C led by Greenoaks and Sequoia, with Alphabet still putting money in. Hassabis says AI can cut the time and cost of finding new medicines. That puts Alphabet on the field in health, not only search and cloud, and the next test is clinical trials.
Source: @demishassabis on X
